Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19 (2019nCoV_ICU)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04388670 |
Recruitment Status : Unknown
Verified May 2020 by Giacomo Grasselli, Policlinico Hospital.
Recruitment status was: Recruiting
First Posted : May 14, 2020
Last Update Posted : May 14, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
COVID-19 Critical Illness |
Study Type : | Observational |
Estimated Enrollment : | 1500 participants |
Observational Model: | Cohort |
Time Perspective: | Other |
Official Title: | Epidemiological and Clinical Characteristics of Patients With COVID-19 Admitted in Italian Intensive Care Units: a Multicentric Retrospective-prospective Cohort Study. |
Actual Study Start Date : | February 22, 2020 |
Estimated Primary Completion Date : | August 22, 2020 |
Estimated Study Completion Date : | August 31, 2020 |

- Overall number and characteristics of patients with COVID-19 in ICU [ Time Frame: 22nd February - 22nd August 2020 ]Number and characteristics of patients with COVID-19 admitted in Intensive Care Units every week.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Adulthood
- Informed consent obtained
Exclusion Criteria:
- No informed consent obtained

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04388670
Contact: Giacomo Grasselli, MD | +390255033285 | giacomo.grasselli@unimi.it |
Italy | |
Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico | Recruiting |
Milan, Italy, 20100 | |
Contact: Giacomo Grasselli, MD +390255033285 giacomo.grasselli@unimi.it |
Principal Investigator: | Giacomo Grasselli, MD | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico |
Responsible Party: | Giacomo Grasselli, Associate Professor, Policlinico Hospital |
ClinicalTrials.gov Identifier: | NCT04388670 |
Other Study ID Numbers: |
PoliclinicoH |
First Posted: | May 14, 2020 Key Record Dates |
Last Update Posted: | May 14, 2020 |
Last Verified: | May 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
COVID-19 Critical Illness Respiratory Tract Infections Infections Pneumonia, Viral Pneumonia Virus Diseases Coronavirus Infections |
Coronaviridae Infections Nidovirales Infections RNA Virus Infections Lung Diseases Respiratory Tract Diseases Disease Attributes Pathologic Processes |